Neogen Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Neogen Stock Summary

Neogen competes with Heartbeam, EUDA Health, Nutex Health, Healthcare Triangle, and Mangoceuticals, Common. Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan. Neogen Cp operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 2108 people.

Neogen Key Financial Ratios

Neogen Key Balance Sheet Accounts

Neogen Key Income Statement Accounts

Neogen Key Cash Accounts

Neogen Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Neogen's current stock value. Our valuation model uses many indicators to compare Neogen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Neogen competition to find correlations between indicators driving Neogen's intrinsic value. More Info.Neogen is considered to be number one stock in return on equity category among its peers. It is regarded second in return on asset category among its peers . At this time, Neogen's Return On Equity is most likely to slightly decrease in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value Neogen by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Neogen Systematic Risk

Today, most investors in Neogen Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Neogen's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Neogen growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Neogen help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Neogen. We use our internally-developed statistical techniques to arrive at the intrinsic value of Neogen based on widely used predictive technical indicators. In general, we focus on analyzing Neogen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Neogen's daily price indicators and compare them against related drivers.

When running Neogen's price analysis, check to measure Neogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neogen is operating at the current time. Most of Neogen's value examination focuses on studying past and present price action to predict the probability of Neogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neogen's price. Additionally, you may evaluate how the addition of Neogen to your portfolios can decrease your overall portfolio volatility.